{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-091112","form_type":"8-K","ticker":null,"cik":"0001845459","company_name":"NKGen Biotech, Inc.","filed_at":"2025-09-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.328069+00:00","generated_at":"2026-05-17T05:48:50.383402+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"NKGen Biotech sells 10M shares at $0.25 to Asia Advisors for $2.5M, with warrants","bullets":["Issued 10M shares at $0.25 to Asia Advisors Limited, raising $2.5M gross proceeds.","Warrant issued to purchase up to 20M shares at $0.25 (200% of shares bought).","Letter agreement grants option to purchase additional 20M shares at $0.25 within 12 months, with matching warrants.","If outstanding convertible debt warrant exercise prices are reset below $0.25, purchase price and warrant exercise price reset to that lower price.","Securities issued under Section 4(a)(2) and Rule 506; stock trades on OTC Expert Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-091112","json":"https://secwatch.observer/filing/0001213900-25-091112.json","markdown":"https://secwatch.observer/filing/0001213900-25-091112.md","text":"https://secwatch.observer/filing/0001213900-25-091112.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025091112/0001213900-25-091112-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025091112/ea0258284-8k_nkgen.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:48:50.383402+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2c2b03965171b73ebde1017ff137c6eacd509954","claim":"NKGen Biotech, Inc. issued 10,000,000 shares of the Company’s common stock of common stock to Asia Advisors Limited for at a purchase price of $0.25 per share, for an aggregate purchase price of $2,500,000.00.","evidence_excerpt":"On September 18, 2025, NKGen Biotech, Inc. (the “ Company ”) entered into a Stock Purchase Agreement (the “ SPA ”) with Asia Advisors Limited (the “ Purchaser ”), pursuant to which the Company agreed to issue and sell, and the Purchaser agreed to purchase, an aggregate of 10,000,000 shares of the Company’s common stock, par value $0.0001 per share (the “ Shares ”), at a purchase price of $0.25 per share (the “ Share Price ”), for an aggregate purchase price of $2,500,000.00.","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025091112/0001213900-25-091112-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"common stock"},{"label":"Shares","value":"10,000,000 shares of the Company’s common stock"},{"label":"Purchaser","value":"Asia Advisors Limited"},{"label":"Consideration","value":"at a purchase price of $0.25 per share, for an aggregate purchase price of $2,500,000.00"}],"fact_type":"equity_issuance"},{"claim_id":"f1fbd00f1aa7973599bf041af5673693234323bc","claim":"NKGen Biotech, Inc. issued to purchase up to 20,000,000 shares of common stock of warrant to Asia Advisors Limited for exercisable at the Share Price.","evidence_excerpt":"In addition to the Shares, the Company issued to the Purchaser a common stock purchase warrant (the “ Warrant ”) to purchase up to 20,000,000 shares of common stock, exercisable at the Share Price.","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025091112/0001213900-25-091112-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"warrant"},{"label":"Shares","value":"to purchase up to 20,000,000 shares of common stock"},{"label":"Purchaser","value":"Asia Advisors Limited"},{"label":"Consideration","value":"exercisable at the Share Price"}],"fact_type":"equity_issuance"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}